Jim Cramer Believes Johnson & Johnson’s Earnings Should Be the Strongest Among Pharmaceuticals

Johnson & Johnson (NYSE:JNJ) is one of the stocks in Jim Cramer’s game plan for this week. Cramer expects the most from JNJ out of all the companies in the pharmaceutical industry, as he commented: “Beyond the banks, we hear from Johnson & Johnson, which should have the strongest numbers of any pharmaceutical company. The stock shrugged off a bad loss in one of those talc lawsuits where the plaintiff accused J&J of knowingly selling a product that contained a carcinogen, asbestos. I think that the stock d ...